tiprankstipranks
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market
PPLPHARMA
Piramal Pharma Limited
RESEARCH TOOLSreports
Want to see IN:PPLPHARMA full AI Analyst Report?

Piramal Pharma Limited (PPLPHARMA) Ratios

11 Followers

Piramal Pharma Limited Ratios

IN:PPLPHARMA's free cash flow for Q2 2026 was ₹0.26. For the 2026 fiscal year, IN:PPLPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.51- 1.54 1.25 1.26
Quick Ratio
 0.87- 0.93 0.75 0.82
Cash Ratio
 0.26- 0.13 0.08 0.05
Solvency Ratio
 0.05- 0.12 0.10 0.06
Operating Cash Flow Ratio
 0.19- 0.24 0.23 0.13
Short-Term Operating Cash Flow Coverage
 0.72- 0.59 0.48 0.23
Net Current Asset Value
₹ -26.11B₹ -26.11B₹ -17.55B₹ -19.36B₹ -29.14B
Leverage Ratios
Debt-to-Assets Ratio
 0.32- 0.31 0.31 0.39
Debt-to-Equity Ratio
 0.70- 0.60 0.60 0.83
Debt-to-Capital Ratio
 0.41- 0.37 0.37 0.45
Long-Term Debt-to-Capital Ratio
 0.35- 0.28 0.24 0.33
Financial Leverage Ratio
 2.20- 1.93 1.94 2.14
Debt Service Coverage Ratio
 0.60- 0.69 0.48 0.32
Interest Coverage Ratio
 0.27- 1.61 1.16 -0.10
Debt to Market Cap
 0.26- 0.16 0.28 0.68
Interest Debt Per Share
 47.74- 39.38 40.52 49.32
Net Debt to EBITDA
 4.06 4.83 2.64 3.19 6.43
Profitability Margins
Gross Profit Margin
45.23%-60.58%60.08%15.51%
EBIT Margin
3.00%-9.19%7.66%2.40%
EBITDA Margin
12.37%-18.20%16.73%11.95%
Operating Profit Margin
1.02%-7.49%6.36%-0.51%
Pretax Profit Margin
-1.99%-4.58%2.19%-1.70%
Net Profit Margin
-3.67%-1.01%0.22%-2.63%
Continuous Operations Profit Margin
-3.68%-1.01%0.22%-2.63%
Net Income Per EBT
185.12%-21.98%9.94%155.19%
EBT Per EBIT
-194.78%-61.10%34.50%333.94%
Return on Assets (ROA)
-1.81%-1.81%0.58%0.12%-1.28%
Return on Equity (ROE)
-4.01%-3.99%1.12%0.23%-2.75%
Return on Capital Employed (ROCE)
0.68%0.68%5.70%4.75%-0.34%
Return on Invested Capital (ROIC)
0.63%0.63%1.11%0.40%-0.28%
Return on Tangible Assets
-2.36%-2.36%0.79%0.16%-1.85%
Earnings Yield
-1.62%-1.80%0.30%0.11%-2.30%
Efficiency Ratios
Receivables Turnover
 4.11- 3.86 3.80 3.90
Payables Turnover
 1.96- 2.33 2.13 5.02
Inventory Turnover
 1.59- 1.54 1.50 3.56
Fixed Asset Turnover
 1.57- 1.80 1.70 1.59
Asset Turnover
 0.49- 0.58 0.53 0.49
Working Capital Turnover Ratio
 4.20- 5.80 7.83 6.99
Cash Conversion Cycle
 132.78 121.74 174.24 167.92 123.32
Days of Sales Outstanding
 88.80 88.80 94.64 96.07 93.52
Days of Inventory Outstanding
 230.28 172.46 236.31 243.49 102.57
Days of Payables Outstanding
 186.29 139.52 156.72 171.64 72.76
Operating Cycle
 319.08 261.26 330.96 339.56 196.08
Cash Flow Ratios
Operating Cash Flow Per Share
 7.06- 6.66 7.89 3.99
Free Cash Flow Per Share
 3.62- 1.70 2.30 -3.97
CapEx Per Share
 3.44- 4.96 5.59 7.96
Free Cash Flow to Operating Cash Flow
 0.51- 0.26 0.29 -0.99
Dividend Paid and CapEx Coverage Ratio
 1.97- 1.31 1.41 0.47
Capital Expenditure Coverage Ratio
 2.05- 1.34 1.41 0.50
Operating Cash Flow Coverage Ratio
 0.16- 0.18 0.21 0.09
Operating Cash Flow to Sales Ratio
 0.10- 0.10 0.12 0.07
Free Cash Flow Yield
2.15%2.82%0.75%1.77%-5.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -61.91- 331.66 927.86 -43.48
Price-to-Sales (P/S) Ratio
 2.39- 3.34 2.02 1.14
Price-to-Book (P/B) Ratio
 2.47- 3.72 2.09 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
 46.42- 132.61 56.53 -16.86
Price-to-Operating Cash Flow Ratio
 22.68- 33.87 16.46 16.75
Price-to-Earnings Growth (PEG) Ratio
 0.63- 0.84 -8.51 0.29
Price-to-Fair Value
 2.47- 3.72 2.09 1.20
Enterprise Value Multiple
 23.37- 20.97 15.28 16.01
Enterprise Value
 256.45B 225.42B 345.79B 208.88B 135.48B
EV to EBITDA
 23.37 24.46 20.97 15.28 16.01
EV to Sales
 2.89 2.54 3.82 2.56 1.91
EV to Free Cash Flow
 56.17 44.24 151.72 71.41 -28.17
EV to Operating Cash Flow
 28.82 16.11 38.75 20.79 28.00
Tangible Book Value Per Share
 31.91- 30.14 28.45 19.20
Shareholders’ Equity Per Share
 64.78- 60.63 62.15 55.86
Tax and Other Ratios
Effective Tax Rate
 -0.85- 0.78 0.90 -0.55
Revenue Per Share
 70.39- 67.61 64.20 58.40
Net Income Per Share
 -2.59- 0.68 0.14 -1.54
Tax Burden
 1.85 1.85 0.22 0.10 1.55
Interest Burden
 -0.66 -1.95 0.50 0.29 -0.71
Research & Development to Revenue
 0.00 0.00 0.01 0.01 0.01
SG&A to Revenue
 0.27 0.26 0.28 0.03 0.03
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 0.00
Income Quality
 -8.44 -4.29 9.79 56.37 -3.01
Currency in INR